CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 57 filers reported holding CITIUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $105,597 | -63.7% | 154,291 | -36.4% | 0.00% | – |
| Q2 2023 | $290,942 | +2660.6% | 242,452 | +1717.5% | 0.00% | – |
| Q4 2022 | $10,539 | -94.8% | 13,340 | -94.0% | 0.00% | – |
| Q2 2022 | $203,000 | -24.0% | 221,256 | +48.5% | 0.00% | – |
| Q1 2022 | $267,000 | +196.7% | 149,034 | +155.3% | 0.00% | – |
| Q4 2021 | $90,000 | -77.6% | 58,386 | -70.4% | 0.00% | – |
| Q3 2021 | $401,000 | +1.3% | 197,121 | +73.3% | 0.00% | – |
| Q2 2021 | $396,000 | +1000.0% | 113,764 | +882.9% | 0.00% | – |
| Q3 2017 | $36,000 | – | 11,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 196,867 | $181,000 | 0.05% |
| Wealth Advisory Solutions, LLC | 156,850 | $144,000 | 0.04% |
| Horst & Graben Wealth Management LLC | 75,722 | $70,000 | 0.02% |
| Ergoteles LLC | 451,890 | $416,000 | 0.01% |
| Miller Investment Management, LP | 50,000 | $46,000 | 0.01% |
| Virtu Financial LLC | 81,410 | $75,000 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 17,342 | $16,000 | 0.00% |
| Kestra Advisory Services, LLC | 71,102 | $65,000 | 0.00% |
| Csenge Advisory Group | 15,000 | $14,000 | 0.00% |
| Qube Research & Technologies Ltd | 121,281 | $112,000 | 0.00% |